0026

Yantai Dongcheng Pharmaceutical Co., Ltd. (002675)

Market Closed
11 Jul, 06:57
XSHE XSHE
¥
14. 36
+0.01
+0.07%
¥
11.9B Market Cap
- P/E Ratio
0.5% Div Yield
8,431,800 Volume
- Eps
¥ 14.35
Previous Close
Day Range
14.3 14.58
Year Range
11.37 16.35
Want to track 002675 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

002675 closed Friday higher at ¥14.36, an increase of 0.07% from Thursday's close, completing a monthly increase of 0.07% or ¥0.01. Over the past 12 months, 002675 stock gained 17.13%.
002675 is not paying dividends to its shareholders.
The last earnings report, released on May 16, 2025, missed the consensus estimates by -0.14%. On average, the company has fell short of earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XSHE (CNY).

002675 Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.

Yantai Dongcheng Pharmaceutical Co., Ltd. Dividends

0026
002675 1 month ago
Other
¥0.03 Per Share
0026
002675 6 months ago
Other
¥0.05 Per Share
0026
002675 24 Jun 2024
Other
¥0.13 Per Share
0026
002675 10 Jul 2023
Other
¥0.15 Per Share
0026
002675 9 Jun 2022
Other
¥0.15 Per Share

Yantai Dongcheng Pharmaceutical Co., Ltd. Earnings

16 May 2025 Date
0.16
Cons. EPS
0.02
EPS
29 Oct 2024 Date
-
Cons. EPS
0.07
EPS
31 Aug 2024 Date
-
Cons. EPS
0.06
EPS
17 May 2024 Date
-
Cons. EPS
-
EPS
26 Oct 2023 Date
-
Cons. EPS
0.12
EPS
0026
002675 1 month ago
Other
¥0.03 Per Share
0026
002675 6 months ago
Other
¥0.05 Per Share
0026
002675 24 Jun 2024
Other
¥0.13 Per Share
0026
002675 10 Jul 2023
Other
¥0.15 Per Share
0026
002675 9 Jun 2022
Other
¥0.15 Per Share
16 May 2025 Date
0.16
Cons. EPS
0.02
EPS
29 Oct 2024 Date
-
Cons. EPS
0.07
EPS
31 Aug 2024 Date
-
Cons. EPS
0.06
EPS
17 May 2024 Date
-
Cons. EPS
-
EPS
26 Oct 2023 Date
-
Cons. EPS
0.12
EPS

Yantai Dongcheng Pharmaceutical Co., Ltd. (002675) FAQ

What is the stock price today?

The current price is ¥14.36.

On which exchange is it traded?

Yantai Dongcheng Pharmaceutical Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 002675.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.5%.

What is its market cap?

As of today, the market cap is 11.9B.

Has Yantai Dongcheng Pharmaceutical Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Yantai Dongcheng Pharmaceutical Co., Ltd. Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
Mr. Zhi Gang Luo CEO
XSHE Exchange
CNE100001DP5 ISIN
CN Country
2,469 Employees
- Last Dividend
30 Aug 2016 Last Split
25 May 2012 IPO Date

Overview

Yantai Dongcheng Pharmaceutical Group Co., Ltd., a conglomerate in the pharmaceutical industry, with its subsidiaries, delves into the production and distribution of biochemical Active Pharmaceutical Ingredients (APIs), finished dosage forms, nuclide drugs, and health-related products. These offerings cater to several therapeutic domains, including cardiovascular diseases, antitumor, urology, orthopedics, among others. Established in 1998, this enterprise has its roots and headquarters in Yantai, China, and has expanded its market footprint across approximately 40 countries and regions worldwide, covering Europe, the Americas, Asia Pacific, and other international territories.

Products and Services

  • APIs and Healthcare Products: The company produces essential biochemical APIs like heparin, chondroitin sulphate sodium and calcium, glucosamine series products, along with other critical healthcare products including collagen, hyaluronic acid, and cytochrome C. These ingredients and products are vital for various health supplements and medications.
  • Prescription Medications: Offering a range of prescription drugs, Dongcheng Pharmaceutical provides solutions such as nadroparin calcium, hydrocortisone sodium succinate, chorionic gonadotrophin, and menotropins for injection. Additionally, it manufactures ambroxol hydrochloride dispersible tablets, jinjunling capsule, metformin hydrochloride and glibenclamide tablets, clemastine fumarate tablets, and wind dispelling itch relieving granule for various medical conditions.
  • Nuclide Drugs: The firm is a key player in the production of nuclide drugs used in diagnostic imaging and treatment of diseases. Products include Technetium [99Tc] Methylene Diphosphonate Injection and Technetium [99mTc] Tc labeled tracers for imaging, 2-[18F]FDG to detect tumor cell activity, sodium iodide [131I] oral solution and iodine [125I] seed for internal radiation treatment of malignant tumors, and [14C]Urea capsule for specific diagnostic uses.
  • Nutritional Supplements: Furthermore, Yantai Dongcheng Pharmaceutical Group provides health supplements like the jiabaolin glucosamine chondroitin sulfate capsule, catering to nutritional needs and overall well-being.

Contact Information

Address: No.7 ChangBaiShan Road, Yantai, China, 264006
Phone: 86 53 5639 1521